Harmony Biosciences Holdings, Inc. /
Zynerba Pharmaceuticals, Inc.
Harmony Biosciences completes Zynerba acquisition
What happened
Harmony Biosciences Holdings, Inc. completed its acquisition of Zynerba Pharmaceuticals, Inc. on Oct. 10, 2023. Zynerba became a wholly owned subsidiary of Harmony.
The tender offer included $60 million in cash and one contingent value right per share, with potential additional payments tied to clinical, regulatory and sales milestones.
The source
Everything on this page comes from the source below.
Harmony Biosciences completes Zynerba acquisition
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly